Rescue of the HNF4 → HNF1α Pathway in Hepatoma Variant Cells Containing Human Chromosome 12

Expression of liver-enrichedtrans-acting hepatocyte nuclear factors 1α (HNF1α) and 4 (HNF4) is correlated with the hepatic phenotype in cultured rat hepatoma cells. We have used a hepatoma variant cell line, H11, that specifically lacks the HNF4 → HNF1α pathway as a model to understand mechanisms controlling hepatic gene expression. We have introduced randomly marked human chromosomes into H11 cells and have isolated a number of microcell hybrids that have rescued hepatic gene expression, including HNF4, HNF1α, and α1-antitrypsin. Chromosomal analysis of cell hybrids showed that the rescued hepatic phenotype correlated closely with the presence of human chromosome 12p sequences. Although the gene encoding HNF1α is located on chromosome 12q24, its retention was not required to rescue the hepatic phenotype. Thus, we suggest that a locus on human chromosome 12p plays an important role in maintenance of hepatic gene expression through activation of the HNF4 → HNF1α pathway.     

Cell Research发表HNFα在肝纤维化中的研究进展

<正>肝纤维化不但破坏肝脏结构,还能损害肝脏功能,和许多慢性肝疾病密切相关。肝细胞是维持肝内代谢平衡的关键,但是肝细胞在肝纤维化过程中的作用一直不甚清楚。在肝细胞行使功能的过程中,肝脏内广泛存在的转录因子HNF1α起着至关重要的作用。以往研究表明HNF1α对肝癌有显著的抑制作用,近期Cell Research发表的第二军医大学谢渭芬实验室的研究成果显示,HNF1α的表达能够显著抑制人和     

HNF1α对人FXR 启动子的调控作用

为探讨肝细胞核因子1α（HNF1α）对人胆汁酸受体（FXR）转录激活的作用及机制,将含HNF1α的真核表达载体（pcDNA3.1(+)HNF1α）和含有FXR启动子的荧光素酶报告基因载体共转染人肝癌细胞系HepG2,检测转染细胞中荧光素酶活性并用半定量RT-PCR、免疫印迹法检测FXR的表达.QuikChange法对FXR启动子HNF1α可能结合位点进行突变,将包含突变点的重组荧光素酶报告质粒单独或与pcDNA3.1(+)共同转染HepG2细胞,检测各组荧光素酶活性.根据凝胶电泳迁移率变化,分析HNF1α与FXR启动子区域的结合.结果发现,转染pcDNA 3.1(+)HNF1α可以上调FXR在HepG2细胞中的表达,并增强FXR启动子活性且具有剂量依赖性;－65～－48区域的点突变,导致FXR启动子活性明显降低,共转染pcDNA3.1(+)HNF1α也不具有增强作用.结果提示,转录因子HNF1α能调控FXR基因表达,其机制为：HNF1α与FXR启动子区域－65～－48区域的反向半位点结合,发挥其反式激活作用.     

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis

Hepatocyte nuclear factor 4α (HNF4α) is essential for liver development and hepatocyte function. Here, we show that transient inhibition of HNF4α initiates hepatocellular transformation through a microRNA-inflammatory feedback loop circuit consisting of miR-124, IL6R, STAT3, miR-24, and miR-629. Moreover, we show that, once this circuit is activated, it maintains suppression of HNF4α and sustains oncogenesis. Systemic administration of miR-124, which modulates inflammatory signaling, prevents and suppresses hepatocellular carcinogenesis by inducing tumor-specific apoptosis without toxic side effects. As we also show that this HNF4α circuit is perturbed in human hepatocellular carcinomas, our data raise the possibility that manipulation of this microRNA feedback-inflammatory loop has therapeutic potential for treating liver cancer.     

Role of PPARα and HNF4α in Stress-Mediated Alterations in Lipid Homeostasis

Stress is a risk factor for several cardiovascular pathologies. PPARα holds a fundamental role in control of lipid homeostasis by directly regulating genes involved in fatty acid transport and oxidation. Importantly, PPARα agonists are effective in raising HDL-cholesterol and lowering triglycerides, properties that reduce the risk for cardiovascular diseases. This study investigated the role of stress and adrenergic receptor (AR)-related pathways in PPARα and HNF4α regulation and signaling in mice following repeated restraint stress or treatment with AR-antagonists administered prior to stress to block AR-linked pathways. Repeated restraint stress up-regulated Pparα and its target genes in the liver, including Acox, Acot1, Acot4, Cyp4a10, Cyp4a14 and Lipin2, an effect that was highly correlated with Hnf4α. In vitro studies using primary hepatocyte cultures treated with epinephrine or AR-agonists confirmed that hepatic AR/cAMP/PKA/CREB- and JNK-linked pathways are involved in PPARα and HNF4α regulation. Notably, restraint stress, independent of PPARα, suppressed plasma triglyceride levels. This stress-induced effect could be attributed in part to hormone sensitive lipase activation in the white adipose tissue, which was not prevented by the increased levels of perilipin. Overall, this study identifies a mechanistic basis for the modification of lipid homeostasis following stress and potentially indicates novel roles for PPARα and HNF4α in stress-induced lipid metabolism.     

热量限制通过HNF3γ下调NOX4表达来抑制内皮细胞的衰老

为了观察热量限制对主动脉内皮细胞中HNF3γ及NOX4基因表达的影响, 揭示HNF3γ-NOX4-活性氧通路介导热量限制抗内皮细胞衰老的分子机制, 文章将主动脉内皮细胞分为5组：对照组、高热量组、低热量组、siRNA+低热量组、siRNA+高热量组。应用逆转录实时定量PCR(Real-time quantitative PCR, RT-qPCR)、Western blotting分析各组HNF3γ、NOX4 mRNA及蛋白水平变化, 并检测各组细胞内活性氧产量及细胞衰老程度变化。采用染色质免疫共沉淀分析HNF3γ蛋白与NOX4基因启动子区域结合情况, 萤光素酶报告基因检测HNF3γ蛋白结合后对NOX4基因启动子活性的影响。结果显示：与对照组比较, 低热量组HNF3γ mRNA和总HNF3γ蛋白表达水平、磷酸化/总HNF3γ比值显著升高(P<0.05), NOX4 mRNA和蛋白表达水平、细胞内活性氧产量及细胞衰老程度显著降低(P<0.05); 高热量组HNF3γ mRNA和总HNF3γ蛋白表达水平、磷酸化/总HNF3γ比值显著降低(P<0.05), NOX4 mRNA和蛋白表达水平、细胞内活性氧产量及细胞衰老程度显著升高(P<0.05); siRNA+低热量组及siRNA+高热量组中NOX4 mRNA和蛋白表达水平、细胞内活性氧水平及细胞衰老程度显著升高(P< 0.05)。染色质免疫共沉淀证实HNF3γ蛋白可与NOX4基因启动区域4个结合位点(-6 bp、-76 bp、-249 bp、-954 bp)结合。萤光素酶报告基因检测显示HNF3γ蛋白与NOX4启动子区域1个位点(-6 bp)、2个位点(-6、-76 bp)、3个位点(-6、-76、-249 bp)、4个位点(-6、-76、-249、-954 bp)结合, 可使NOX4启动子活性分别降低至对照组的80.15±4.64%、40.02.±2.15%、16.46±2.24%、12.13±1.46%, P<0.05。上述结果提示热量限制可上调HNF3γ基因表达, 增强HNF3γ蛋白活性, 促进HNF3γ蛋白同NOX4基因启动子区域结合, 抑制NOX4基因表达, 进而减少细胞内活性氧产生而延缓动脉内皮细胞衰老。     

MODY3相关蛋白HNF1α第249位丝氨酸突变导致小鼠葡萄糖代谢异常

肝细胞核因子1α(HNF1α)不仅是调节葡萄糖代谢的重要转录因子,还参与肝、胰等多个器官中蛋白质合成、物质代谢、增殖分化相关基因的表达调控。HNF1α突变或表达异常引发包括青少年糖尿病3型(maturity onset diabetes of young 3,MODY3)在内的多种代谢疾病。Ser249是HNF1α重要的功能位点,该位点受ATM蛋白激酶直接磷酸化修饰,并可能是ATM蛋白激酶影响葡萄糖代谢的效应靶点,也可能是共济失调毛细血管扩张症(ataxia telangiectasia,AT)患者糖代谢异常的致病靶点。为进一步研究Ser249磷酸化在体内的功能,本文构建人源野生型HNF1α转基因小鼠(WT小鼠)和HNF1αS249A转基因小鼠(S249A小鼠),对其基础代谢水平和葡萄糖代谢能力进行检测。相较于对照小鼠,S249A小鼠的多项基础代谢指标异常,WT小鼠未显示差异;但当小鼠接受刺激后,无论是注射葡萄糖,还是丙酮酸或胰岛素,相较于各自的对照小鼠,WT小鼠都表现出更强的反应性,而S249A小鼠的糖异生反应和胰岛素敏感性均未显示出差异。实时定量PCR结果表明,WT小鼠肝的多个糖代谢基因表达上调,但S249A小鼠肝中糖代谢基因上调幅度明显小于WT小鼠。本研究提示,HNF1αSer249突变导致小鼠糖代谢异常,可能与磷酸化修饰失调进而影响其转录活性有关。     

HNF4α Combinatorial Isoform Heterodimers Activate Distinct Gene Targets that Differ from Their Corresponding Homodimers

1. Download high-res image (207KB)
2. Download full-size image